432 related articles for article (PubMed ID: 20370710)
1. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Saario S; Nevalainen T
Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
[TBL] [Abstract][Full Text] [Related]
2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
3. New insights into endocannabinoid degradation and its therapeutic potential.
Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid CB
Leonard MZ; Alapafuja SO; Ji L; Shukla VG; Liu Y; Nikas SP; Makriyannis A; Bergman J; Kangas BD
J Pharmacol Exp Ther; 2017 Dec; 363(3):314-323. PubMed ID: 28947487
[TBL] [Abstract][Full Text] [Related]
7. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
Wiley JL; Walentiny DM; Wright MJ; Beardsley PM; Burston JJ; Poklis JL; Lichtman AH; Vann RE
Eur J Pharmacol; 2014 Aug; 737():97-105. PubMed ID: 24858366
[TBL] [Abstract][Full Text] [Related]
9. The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.
Alvarez-Jaimes LJ; Palmer JA
Curr Pharm Biotechnol; 2011 Oct; 12(10):1644-59. PubMed ID: 21466449
[TBL] [Abstract][Full Text] [Related]
10. Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons.
Marrs WR; Horne EA; Ortega-Gutierrez S; Cisneros JA; Xu C; Lin YH; Muccioli GG; Lopez-Rodriguez ML; Stella N
J Biol Chem; 2011 Aug; 286(33):28723-28728. PubMed ID: 21665953
[TBL] [Abstract][Full Text] [Related]
11. Fatty pain cures.
Imming P
Chem Biol; 2007 Dec; 14(12):1311-2. PubMed ID: 18096498
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
13. Focus on the three key enzymes hydrolysing endocannabinoids as new drug targets.
Vandevoorde S; Lambert DM
Curr Pharm Des; 2005; 11(20):2647-68. PubMed ID: 16101463
[TBL] [Abstract][Full Text] [Related]
14. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
Guindon J; Guijarro A; Piomelli D; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations.
Siegmund SV; Wojtalla A; Schlosser M; Zimmer A; Singer MV
Biochem Biophys Res Commun; 2013 Jul; 437(1):48-54. PubMed ID: 23806692
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
Kinsey SG; O'Neal ST; Long JZ; Cravatt BF; Lichtman AH
Pharmacol Biochem Behav; 2011 Mar; 98(1):21-7. PubMed ID: 21145341
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
Lau BK; Drew GM; Mitchell VA; Vaughan CW
Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.
Hruba L; Seillier A; Zaki A; Cravatt BF; Lichtman AH; Giuffrida A; McMahon LR
J Pharmacol Exp Ther; 2015 May; 353(2):261-8. PubMed ID: 25711338
[TBL] [Abstract][Full Text] [Related]
19. Novel natural and synthetic ligands of the endocannabinoid system.
Hanus LO; Mechoulam R
Curr Med Chem; 2010; 17(14):1341-59. PubMed ID: 20166928
[TBL] [Abstract][Full Text] [Related]
20. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes.
Saario SM; Savinainen JR; Laitinen JT; Järvinen T; Niemi R
Biochem Pharmacol; 2004 Apr; 67(7):1381-7. PubMed ID: 15013854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]